| Ytd | -5.73% | |
| 1y | 6.75% |
| Open | 4.11 | Prev Close | 4.00 | Low | 4.11 | High | 4.11 | Mkt Cap | 154.17M |
| Vol | 560.00 | Avg Vol | 6.31K | EPS | -1.94 | P/E | -2.12 | Forward P/E | -2.96 |
| Beta | 1.08 | Short Ratio | 4.49 | Inst. Own | 5.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-12 | 50-d Avg | 3.95 | 200-d Avg | 4.19 | 1yr Est | 10.37 |
Randomized Phase 2 study in front-line setting progressing well, with nine sites actively recruiting
Developing bispecific Radio-DARPins to engage multiple tumor targets simultaneously, improving preci
Phase 1/2a trial of MP0712, 212Pb-based DLL3-targeted Radio-DARPin co-developed with Orano Med: Dosi
Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712Dosing ongoing
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for
On Tuesday, 250 stocks hit new 52-week lows.
Tuesday's session saw 211 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.